背后的机制 高度诱导和 3 组肺高血压
Giuseppina Milano1, Sara Ottolenghi2,3, Gustavo Zubieta-Calleja4
1Department Coeur-Vaisseaux, Cardiac Surgery Center, University Hospital of Lausanne, 1005 Lausanne, Switzerland.
International journal of molecular sciences
|January 28, 2026
概括
缺氧诱导的肺高血压涉及复杂的分子途径,如氧化还原失衡和炎症. 了解这些机制对于开发有效治疗这种严重的肺部疾病至关重要.
科学领域:
- 心血管研究研究心血管研究
- 肺部医学 肺部医学
- 分子生物学分子生物学
背景情况:
- 肺高血压 (PH) 影响全球1%的人口,随着年龄的增长而增加.
- 它经常复杂化慢性肺/心脏疾病,但也可能源于慢性缺氧,例如,在高海拔地区.
- 持续的缺氧驱动肺血管收缩和血管重塑,提高肺动脉压力.
研究的目的:
- 审查低氧-肺高血压轴的分子机制.
- 探索涉及疾病病原发生的相互连接的信号网络.
- 识别知识差距和潜在的治疗目标.
主要方法:
- 关于分子机制的文献综述.
- 专注于信号通路,包括氧化还原,PI3K-Akt,NO生物可用性,自和代谢重编程.
- 重点是偶然的重塑和纤维细胞参与.
主要成果:
- 低氧会引发肺血管收缩和血管重塑.
- 关键的途径包括氧化还原失衡,PI3K-Akt信号传递,氧化生物可用性,自,线粒体动力学,代谢重编程,炎症和随机重塑.
- 红色素信号传递也与此有关.
结论:
- 缺氧-肺高血压轴是由复杂的,相互连接的分子信号驱动的.
- 虽然存在治疗目标,但由于疾病的多因素性质,将其转化为临床实践仍然具有挑战性.
- 为了有效的治疗开发,需要对这些综合途径进行进一步的研究.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
632
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
632
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
595
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
595
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
464
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
464
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
495
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
495
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
612
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
612
Mechanisms of Retrovirus-induced Cancers
7.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K


